Biography and Research Information

OverviewAI-generated summary

Ryan K. Dare's research focuses on clinical outcomes and treatment strategies for infectious diseases. His work has investigated the efficacy of various therapeutic agents, including abatacept, cenicriviroc, and infliximab, for patients hospitalized with COVID-19 pneumonia. Dare has also studied risk factors associated with blood culture contamination and the impact of rapid diagnostic testing, such as the Accelerate PhenoTest BC Kit, on improving outcomes and antibiotic stewardship in patients with bloodstream infections. His research extends to identifying risk factors for mortality and disease progression in COVID-19 patients within the Southeast region of the United States.

Further investigations by Dare include the development of cefiderocol resistance in carbapenem-resistant *Acinetobacter baumannii*, linking it to insertion sequence IS*Aba36*. He has also compared indirect fungal diagnostic tests for patients with proven histoplasmosis and reviewed literature on *Arcanobacterium haemolyticum* bacteremia presenting as severe sepsis. Dare's scholarship metrics include an h-index of 16, with 68 total publications and 1,688 total citations. He has collaborated extensively with researchers at the University of Arkansas for Medical Sciences, including Juan Carlos Rico Crescencio, Brett J. Bailey, Jacob T. Painter, and Jacob M. Keck.

Metrics

  • h-index: 16
  • Publications: 68
  • Citations: 1,688

Selected Publications

  • Use of Aztreonam–Avibactam with Rapid Eravacycline Step-Down Therapy for a Tibial Septic Non-Union by NDM-Producing Enterobacter cloacae (2025) DOI
  • Evaluation of Antibiotic Selection in the Emergency Department Following the Implementation of an Infectious Source-Specific Order Set (2025) DOI
  • Measurement of Practice-Level Antibiotic Utilization in a Medicaid Patient-Centered Medical Home Program (2025) DOI
  • It’s Here, It’s There, There’s Fungi Everywhere: A Case Series Utilizing Rezafungin for Invasive Candidiasis (2025) DOI
  • P-842. Community-onset vs. Hospital-onset <i>Staphylococcus aureus</i> Bacteremia: Implications for Patients and Healthcare Systems (2025) DOI
  • Dalbavancin Use in Bone and Joint Infections (2024) DOI
  • Diagnostic utility of nasal methicillin-resistant <i>Staphylococcus aureus</i> polymerase chain reaction testing in head and neck infection (2024) DOI
  • Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i> (2024) DOI
  • Fractal Changes of the Retinal Microvasculature in Syphilitic Uveitis (2024) DOI
  • A Tale of Mummified Eggs in Urine of a US Veteran (2024) DOI
  • 159. Diagnostic Utility of Nasal Methicillin-resistant <i>Staphylococcus aureus</i> Polymerase Chain Reaction Testing in Head and Neck Infection (2023) DOI
  • 2902. Dalbavancin Use in Bone and Joint Infections (2023) DOI
  • Development of VRE meningitis due to haematogenous spread while on high-dose daptomycin therapy (2023) DOI
  • INITIAL MEDICAL MANAGEMENT WITH DELAYED TRANSCATHETER VALVE REPLACEMENT IN BARTONELLA HENSELAE BIOPROSTHETIC VALVE ENDOCARDITIS (2023) DOI
  • COVID-19 Monoclonal Antibody Administration Linked to Drop in Blood Pressure: A Retrospective Cohort Study (2023) DOI

Grants & Funding

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics